The importance of early symptom recognition in the context of early detection and cancer survival

European Journal of Cancer

Volumn 45, Issue 16, 2009, Pages 2743-2748

  Ott, J J ^a   Ullrich, A ^a   Miller, A B ^b  

^a World Health Organisation   (Switzerland)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Awareness; Early detection of cancer; Neoplasms; Primary health care; Signs and symptoms

Indexed keywords

ANUS CANCER; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER SURVIVAL; COLORECTAL CANCER; GYNECOLOGIC CANCER; HEAD AND NECK CANCER; HUMAN; LIVER CANCER; LUNG CANCER; MOUTH CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RETINOBLASTOMA; SKIN CANCER; STOMACH CANCER; TESTIS CANCER; THYROID CANCER; UTERINE CERVIX CANCER;

EARLY DETECTION OF CANCER; HEALTH PROMOTION; HUMANS; NEOPLASM STAGING; NEOPLASMS; TERMINOLOGY AS TOPIC;

EID: 70350108831     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.08.009     Document Type: Article

References (57)

1. Strong K., Mathers C., Epping-Jordan J., Resnikoff S., and Ullrich A. Preventing cancer through tobacco and infection control: how many lives can we save in the next 10 years?. Eur J Cancer Prev 17 (2008) 153-161
2. Mathers C.D., and Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3 (2006) e442
3. World Health Organization. Cancer control. Knowledge into action. WHO Guide for effective programmes: early detection (2007), World Health Organization, Geneva
4. Austin D.F., and Dunn J.E. Cancer symptoms, clinical stage, and survival rates. Am J Public Health 70 (1980) 474-475
5. Vakil N., Moayyedi P., Fennerty M.B., and Talley N.J. Limited value of alarm features in the diagnosis of upper gastrointestinal malignancy: systematic review and meta-analysis. Gastroenterology 131 (2006) 390-401
6. Keddie N., and Hargreaves A. Symptoms of carcinoma of the colon and rectum. Lancet 292 (1968) 749-750
7. Korsgaard M., Pedersen L., Sorensen H.T., and Laurberg S. Delay of treatment is associated with advanced stage of rectal cancer but not of colon cancer. Cancer Detect Prev 30 (2006) 341-346
8. Curless R., French J., Williams G.V., and James O.F. Comparison of gastrointestinal symptoms in colorectal carcinoma patients and community controls with respect to age. Gut 35 (1994) 1267-1270
9. Pitchers M., and Martin C. Delay in referral of oropharyngeal squamous cell carcinoma to secondary care correlates with a more advanced stage at presentation, and is associated with poorer survival. Br J Cancer 94 (2006) 955-958
10. Pontén J., Adami H.O., Bergström R., et al. Strategies for global control of cervical cancer. Int J Cancer 60 (1995) 1-26
11. Summerton N. General practitioners and cancer: primary care oncology needs more research if it is to develop. BMJ 320 (2000) 1090-1091
12. Teppo L., Dickman P.W., Hakulinen T., et al. Cancer patient survival - patterns, comparisons, trends - a population-based Cancer Registry study in Finland. Acta Oncol 38 (1999) 283-294
13. Carter C.L., and Allen C. Henson. Relation of tumour size, lymph node status, and survival in 24, 740 breast cancer cases. Cancer 63 (1989) 181-187
14. Maguire A., Porta M., Malats N., et al. Cancer survival and the duration of symptoms. An analysis of possible forms of the risk function. Eur J Cancer 30 (1994) 785-792
15. Porta M., Gallén M., Malats N., and Planas J. Influence of "diagnostic delay" upon cancer survival: an analysis of five tumour sites. J Epidemiol Community Health 45 (1991) 225-230
16. Richards M.A., Westcombe A.M., Love S.B., Littlejohns P., and Ramirez A.J. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet 353 (1999) 1119-1126
17. Sant M., Allemani C., Capocaccia R., et al. Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer 106 (2003) 416-422
18. Horn L.C., Fischer U., Raptis G., Bilek K., and Hentschel B. Tumor size is of prognostic value in surgically treated FIGO stage II cervical cancer. Gynecol Oncol 107 (2007) 310-315
19. Barchielli A., Amorosi A., Balzi D., Crocetti E., and Nesi G. Long-term prognosis of gastric cancer in a European country: a population-based study in Florence (Italy). 10-year survival of cases diagnosed in 1985-1987. Eur J Cancer 37 (2001) 1674-1680
20. Gann P.H. Interpreting recent trends in prostate cancer incidence and mortality. Epidemiology 8 (1997) 117-120
21. Vis A.N., Roemeling S., Reedijk A.M., Otto S.J., and Schröder F.H. Overall survival in the intervention arm of a randomized controlled screening trial for prostate cancer compared with a clinically diagnosed cohort. Eur Urol 53 (2008) 91-98
22. Wang J.H., Changchien C.S., Hu T.H., et al. The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma - survival analysis of 3892 patients. Eur J Cancer 44 (2008) 1000-1006
23. Hellsten S., Ljungerud G., and Glifberg I. Bladder carcinoma. Long-term survival and late recurrence. Scand J Urol Nephrol 17 (1983) 57-61
24. Kirsner R.S., Wilkinson J.D., Ma F., Pacheco H., and Federman D.G. The association of Medicare health care delivery systems with stage at diagnosis and survival for patients with melanoma. Arch Dermatol 141 (2005) 753
25. Sargeran K., Murtomaa H., Safavi S.M., Vehkalahti M.M., and Teronen O. Survival after diagnosis of cancer of the oral cavity. Br J Oral Maxillofac Surg 46 (2008) 187-191
26. Subramanian S., Sankaranarayanan R., Bapat B., et al. Cost-effectiveness of oral cancer screening: results from a cluster randomized controlled trial in India. Bull World Health Organ 87 (2009) 200-206
27. Cicolallo L., Capocaccia R., Coleman M.P., et al. Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery. Gut 54 (2005) 268-273
28. Ponz de Leon M., Benatti P., Di Gregorio C., et al. Staging and survival of colorectal cancer: are we making progress? The 14-year experience of a specialized cancer registry. Dig Liver Dis 32 (2000) 312-317
29. Gonzalez-Hermoso F., Perez-Palma J., Marchena-Gomez J., Lorenzo-Rocha N., and Medina-Arana V. Can early diagnosis of symptomatic colorectal cancer improve the prognosis?. World J Surg 28 (2004) 716-720
30. Olsson L., Bergkvist L., and Exbom A. Symptom duration versus survival in non-emergency colorectal cancer. Scand J Gastroenterol 39 (2004) 252-258
31. Ramos M., Esteva M., Cabeza E., Llobera J., and Ruiz A. Lack of association between diagnostic and therapeutic delay and stage of colorectal cancer. Eur J Cancer 44 (2008) 510-521
32. Stapley S., Peters T.J., Sharp D., and Hamilton W. The mortality of colorectal cancer in relation to the initial symptom at presentation to primary care and to the duration of symptoms: a cohort study using medical records. Br J Cancer 95 (2006) 1321-1325
33. Arbman G., Nilsson E., Störgren-Fordell V., and Sjödahl R. A short diagnostic delay is more important for rectal cancer than for colonic cancer. Eur J Surg 162 (1966) 899-904
34. Wittekind Ch., and Sobin L.H. TNM classification of malignant tumours (2002), Wiley-Liss, New York
35. NICE. National Institute for Health and Clinical Excellence. Referral guidelines for suspected Cancer (2005), NICE, London
36. Summerton N. Diagnosing cancer in primary care (1999), Radcliffe Medical Press
37. Jones R., Latinovic R., Charlton J., and Gulliford M. Alarm symptoms in early diagnosis of cancer in primary care: cohort study using General Practice Research Database. BMJ 334 (2007) 1040
38. Barr L., Cowan R., and Nicolson M. Oncology. 2nd ed. (2004), Elsevier, Edinburgh
39. Langenbach R., Schmidt J., Neumann J., and Zirngibl H. Delay in treatment of colorectal cancer: multifactorial problem. World J Surg 27 (2003) 304-308
40. Barret J., Jiwa M., Rose P., and Hamilton W. Pathways to the diagnosis of colorectal cancer: an observational study in three UK cities. Fam Pract 23 (2006) 15-19
41. Schmoll HJ, Höffken K, Possinger K, editors. Kompedium internistische onkologie. Standards in diagnostik und therapie. Teil 2. 4. Auflage. Heidelberg: Springer; 2006.
42. Hákkinen I.P., Nylamo E.I., and Sóderstróm K.O. The importance of self-observation of fecal blood in indicating a proper bowel examination. Cancer Detect Prev 21 (1997) 267-272
43. DeAntoni E., Crawford E.D., Stone N.N., et al. Prostate Cancer Awareness Week, 1992: a summary of key findings. Clin Invest Med 16 (1993) 448-457
44. Michielutte R., Dignan M.B., Wells H.B., Young L.D., Jackson D.S., and Sharp P.C. Development of a community cancer education program: the Forsyth County, NC cervical cancer prevention project. Public Health Rep 104 (1989) 542-551
45. McCulloch P., Brown P., Martin B., and Williams E. The effects of an awareness-raising program for patients and primary care physicians on the early detection of gastro-oesophageal cancer. Surgery 133 (2003) 154-161
46. Arvanitakis C., Nikopoulos A., Giannoulis E., Theoharidis A., Georgilas V., and Fotiou H. The impact of early or late diagnosis on patient survival in gastric cancer in Greece. Hepato-Gastroenterology 39 (1992) 355-357
47. Rothwell J.F., Feehan E., Reid I., Walsh T.N., and Hennessy T.P. Delay in treatment for oesophageal cancer. Br J Surg 84 (1997) 690-693
48. Macdonald S., Macleod U., Campbell N.C., Weller D., and Mitchell E. Systematic review of factors influencing patient and practitioner delay in diagnosis of upper gastrointestinal cancer. Br J Cancer 94 (2006) 1272-1280
49. Yardley C., Glover C., and Allen-Mersh T.G. Demographic factors associated with knowledge of colorectal cancer symptoms in a UK population-based survey. Ann R Coll Surg Engl 82 (2000) 205-209
50. Linsell L., Burgess C.C., and Ramirez A.J. Breast cancer awareness among older women. Br J Cancer 99 (2008) 1221-1225
51. Dalton S.O., Schüz J., Engholm G., et al. Social inequalities in incidence of survival from cancer in a population-based study in Denmark, 1994-2003: summary of findings. Eur J Cancer 44 (2008) 2074-2086
52. Hansen H.P., Olesen F., Sorensen H.T., Sokolowski I., and Sondergaard J. Socioeconomic patient characteristics predict delay in cancer diagnosis: a Danish cohort study. BMC Health Serv Res 8 (2008) 49
53. Neal R.D., and Allgar V.L. Sociodemographic factors and delays in the diagnosis of six cancers: analysis of data from the National Survey of NHS Patients: Cancer. Br J Cancer 92 (2005) 1971-1975
54. Mandelblatt J., Andrews H., Kerner J., Zauber A., and Burnett W. Determinants of late stage diagnosis of breast and cervical cancer: the impact of age, race, social class and hospital type. Am J Public Health 81 (1991) 646-649
55. Richardson J.L., Langholz B., Bernstein L., Burciaga C., Danley K., and Ross R.K. Stage and delay in breast cancer diagnosis by race, socioeconomic status, age and year. Br J Cancer 65 (1992) 922-926
56. World Health Organization. National cancer control programmes. Policies and managerial guidelines (1993), World Health Organization, Geneva
57. Jatoi I., and Miller A.B. Why is breast cancer mortality declining?. Lancet Oncol 4 (2003) 251-254